Literature DB >> 17140554

Protective effect of Didymocarpus pedicellata on ferric nitrilotriacetate (Fe-NTA) induced renal oxidative stress and hyperproliferative response.

Gurpreet Kaur1, Irshad A Lone, Mohammad Athar, M Sarwar Alam.   

Abstract

Didymocarpus pedicellata R. Br. (Gesneriaceae) is widely used in traditional Indian medicines against renal afflictions. In the present study, we have revealed ethanolic extract of aerial parts of D. pedicellata to possess significant antioxidant activity and protect against ferric nitrilotriacetate (Fe-NTA) mediated renal oxidative stress, nephrotoxicity and tumor promotion response. D. pedicellata extract was found to possess a high content of total polyphenolics, exhibit potent reducing power and significantly scavenge free radicals including several reactive oxygen species (ROS) and reactive nitrogen species (RNS). The extract also significantly and dose-dependently protected against Fe-NTA plus H(2)O(2)-mediated damage to lipids and DNA. Protective efficacy of the extract was also tested in vivo against Fe-NTA mediated nephrotoxicity and tumor promotion response. Administration of Fe-NTA (9 mg/kg body weight, i.p.) to Swiss albino mice depleted renal glutathione content and activities of antioxidant and phase II metabolizing enzymes with concomitant induction of oxidative damage. Fe-NTA also incited hyperproliferation response elevating ornithine decarboxylase activity and [(3)H]-thymidine incorporation into DNA. Elevation in serum creatinine (SCr) and blood urea nitrogen (BUN), and histopathological changes were also evident and suggested Fe-NTA to afflict damage to kidney. Pretreatment of mice with D. pedicellata extract (100-200 mg/kg body weight) for 7 days not only restored antioxidant armory near normal values but also significantly protected against renal oxidative stress and damage restoring normal renal architecture and levels of renal damage markers, viz., BUN and SCr. The results of the present study indicate D. pedicellata to possess potent antioxidant and free radical scavenging activities and preclude oxidative damage and hyperproliferation in renal tissues.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17140554     DOI: 10.1016/j.cbi.2006.10.012

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  5 in total

1.  Novel glycoside from Wedelia calendulacea inhibits diethyl nitrosamine-induced renal cancer via downregulating the COX-2 and PEG2 through nuclear factor-κB pathway.

Authors:  Amita Verma; Bahar Ahmed; Firoz Anwar; Mahfoozur Rahman; Dinesh Kumar Patel; Gaurav Kaithwas; Ravi Rani; Prakash C Bhatt; Vikas Kumar
Journal:  Inflammopharmacology       Date:  2017-02-02       Impact factor: 4.473

2.  Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approach.

Authors:  Bharat B Aggarwal; Sahdeo Prasad; Simone Reuter; Ramaswamy Kannappan; Vivek R Yadev; Byoungduck Park; Ji Hye Kim; Subash C Gupta; Kanokkarn Phromnoi; Chitra Sundaram; Seema Prasad; Madan M Chaturvedi; Bokyung Sung
Journal:  Curr Drug Targets       Date:  2011-10       Impact factor: 3.465

3.  Chemomodulatory effect Melastoma Malabathricum Linn against chemically induced renal carcinogenesis rats via attenuation of inflammation, oxidative stress, and early markers of tumor expansion.

Authors:  Amita Verma; Prakash Chandra Bhatt; Gaurav Kaithwas; Nikunj Sethi; Mohd Rashid; Yashwant Singh; Mahfoozur Rahman; Fahad Al-Abbasi; Firoz Anwar; Vikas Kumar
Journal:  Inflammopharmacology       Date:  2016-09-14       Impact factor: 4.473

4.  Amelioration of renal carcinogenesis by bee propolis: a chemo preventive approach.

Authors:  Summya Rashid; Nemat Ali; Sana Nafees; Syed Kazim Hasan; Sarwat Sultana
Journal:  Toxicol Int       Date:  2013-09

5.  Zanthoxylum heitzii Modulates Ferric Nitrilotriacetate-Dependent Oxidative Alterations in Four Vital Organs: An In Vitro Organoprotective Model.

Authors:  Jacques Joël Essogo; Bruno Moukette Moukette; Francine Nzufo Tankeu; Pauline Nanfack; Constant Anatole Pieme
Journal:  Evid Based Complement Alternat Med       Date:  2017-08-09       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.